InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: BioChica post# 27379

Saturday, 05/10/2014 10:18:55 AM

Saturday, May 10, 2014 10:18:55 AM

Post# of 428746
It will not happan:

a.) wsc is not $168, it's app. $126. The real sales was around 9,6M in Q1 since 10,9M inc. the deferred revenue from previous Q.

b.) KOWA will start end of May / begining of June. "Kowa team should be before the end of this month be fully trained out and promoting Vascepa"

c.) It takes time to them to reach at least the same script level / sales person as the current sales team. "So we anticipate that it will take Kowa multiple calls before they have a major impact relative to prescription writing and maybe a little bit different than normal on the sense that some of these doc have been called on by Amarin in the past, albeit, multiple months back at this juncture. We're not prepared to quantify the extent of their impact. But we would anticipate that, that impact will be increasing throughout the second half of this year and then accelerating beyond that in years going forward"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News